A Multi-center, Randomized, Double-blind, Placebo-controlled Phase IIc Clinical Trial of ALA-PDT in Patients With Cervical Intraepithelial Neoplasia Grade 2 (CIN2) in p16-positivity and High-risk HPV Infection
Latest Information Update: 10 Jun 2024
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Cervical intraepithelial neoplasia
- Focus Therapeutic Use
- Sponsors Shanghai Fudan-Zhangjiang Bio-Pharmaceutical
Most Recent Events
- 10 Jun 2024 New trial record